Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson's disease

Frontiers in Aging Neuroscience

Volumn 8, Issue NOV, 2016, Pages

  Yilmaz, Rezzak ^a   Gräber, Susanne ^a,b   Roeben, Benjamin ^a,b   Suenkel, Ulrike ^a   von Thaler, Anna Katharina ^a   Heinzel, Sebastian ^a,c   Metzger, Florian G ^d   Eschweiler, Gerhard W ^d   Maetzler, Walter ^a,c,d   Berg, Daniela ^a,c   Liepelt Scarfone, Inga ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cognition; Parkinson's disease; Prodromal Parkinson's disease; Substantia nigra hyperechogenicity; Transcranial sonography

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BOSTON NAMING TEST; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE MARKER; DISEASE REGISTRY; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MENTAL PERFORMANCE; MENTAL TEST; PARKINSON DISEASE; REFERENCE VALUE; SCORING SYSTEM; SEMANTICS; SUBSTANTIA NIGRA; VERBAL MEMORY;

EID: 85006274533     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2016.00271     Document Type: Article

References (34)

1. Aarsland, D., Bronnick, K., Larsen, J. P., Tysnes, O. B., Alves, G., and Norwegian ParkWest Study, G. (2009). Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72, 1121-1126. doi: 10.1212/01.wnl.0000338632.00552.cb
2. Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., et al. (2010). Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75, 1062-1069. doi: 10.1212/WNL.0b013e3181f39d0e
3. Adler, C. H. (2011). Premotor symptoms and early diagnosis of Parkinson's disease. Int. J. Neurosci. 121(Suppl. 2), 3-8. doi: 10.3109/00207454.2011.620192
4. Adler, C. H., Connor, D. J., Hentz, J. G., Sabbagh, M. N., Caviness, J. N., Shill, H. A., et al. (2010). Incidental Lewy body disease: clinical comparison to a control cohort. Mov. Disord. 25, 642-646. doi: 10.1002/mds.22971
5. Aebi, C. (2002). Validierung der Neuropsychologischen Testbatterie CERAD-NP. Eine Multi-Center Studie. Dissertation Thesis, University of Basel, Basel
6. Berg, D., Behnke, S., Seppi, K., Godau, J., Lerche, S., Mahlknecht, P., et al. (2013a). Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease. Mov. Disord. 28, 216-219. doi: 10.1002/mds.25192
7. Berg, D., Behnke, S., and Walter, U. (2006). Application of transcranial sonography in extrapyramidal disorders: updated recommendations. Ultraschall Med. 27, 12-19. doi: 10.1055/s-2005-858962
8. Berg, D., Godau, J., Seppi, K., Behnke, S., Liepelt-Scarfone, I., Lerche, S., et al. (2013b). The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur. J. Neurol. 20, 102-108. doi: 10.1111/j.1468-1331.2012.03798.x
9. Berg, D., Merz, B., Reiners, K., Naumann, M., and Becker, G. (2005). Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov. Disord. 20, 383-385. doi: 10.1002/mds.20311
10. Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., et al. (2015). MDS research criteria for prodromal Parkinson's disease. Mov. Disord. 30, 1600-1611. doi: 10.1002/mds.26431
11. Broeders, M., de Bie, R. M., Velseboer, D. C., Speelman, J. D., Muslimovic, D., and Schmand, B. (2013a). Evolution of mild cognitive impairment in Parkinson disease. Neurology, 81, 346-352. doi: 10.1212/WNL.0b013e31829c5c86
12. Broeders, M., Velseboer, D. C., de Bie, R., Speelman, J. D., Muslimovic, D., Post, B., et al. (2013b). Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study. J. Int. Neuropsychol. Soc. 19, 695-708. doi: 10.1017/S1355617713000295
13. Chahine, L. M., Weintraub, D., Hawkins, K. A., Siderowf, A., Eberly, S., Oakes, D., et al. (2016). Cognition in individuals at risk for Parkinson's: parkinson associated risk syndrome (PARS) study findings. Mov. Disord. 31, 86-94. doi: 10.1002/mds.26373
14. Dujardin, K., Duhamel, A., Becquet, E., Grunberg, C., Defebvre, L., and Destee, A. (1999). Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 67, 323-328
15. Foltynie, T., Brayne, C. E., Robbins, T. W., and Barker, R. A. (2004). The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127(Pt 3), 550-560. doi: 10.1093/brain/awh067
16. Hanna-Pladdy, B., Jones, K., Cabanban, R., Pahwa, R., and Lyons, K. E. (2013). Predictors of mild cognitive impairment in early-stage Parkinson's disease. Dement. Geriatr. Cogn. Dis. Extra 3, 168-178. doi: 10.1159/000351421
17. Hoeppner, J., Prudente-Morrissey, L., Herpertz, S. C., Benecke, R., and Walter, U. (2009). Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur. Arch. Psychiatry Clin. Neurosci. 259, 92-97. doi: 10.1007/s00406-008-0840-9
18. Kehagia, A. A., Barker, R. A., and Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol. 9, 1200-1213. doi: 10.1016/S1474-4422(10)70212-X
19. Lezak, M. D. (2012). Neuropsychological Assessment. Oxford: Oxford University Press
20. Liepelt, I., Wendt, A., Schweitzer, K. J., Wolf, B., Godau, J., Gaenslen, A., et al. (2008). Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population. J. Neural Transm. (Vienna) 115, 993-999. doi: 10.1007/s00702-008-0043-6
21. Morris, J. C., Mohs, R. C., Rogers, H., Fillenbaum, G., and Heyman, A. (1988). Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol. Bull. 24, 641-652
22. Muslimovic, D., Post, B., Speelman, J. D., and Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65, 1239-1245. doi: 10.1212/01.wnl.0000180516.69442.95
23. Poletti, M., Frosini, D., Pagni, C., Baldacci, F., Nicoletti, V., Tognoni, G., et al. (2012). Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 83, 601-606. doi: 10.1136/jnnp-2011-301874
24. Pont-Sunyer, C., Hotter, A., Gaig, C., Seppi, K., Compta, Y., Katzenschlager, R., et al. (2015). The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov. Disord. 30, 229-237. doi: 10.1002/mds.26077
25. Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W., et al. (2012). Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov. Disord. 27, 617-626. doi: 10.1002/mds.24996
26. Ross, G. W., Abbott, R. D., Petrovitch, H., Tanner, C. M., and White, L. R. (2012). Pre-motor features of Parkinson's disease: the Honolulu-Asia aging study experience. Parkinsonism Relat. Disord. 18(Suppl. 1), S199-S1202. doi: 10.1016/S1353-8020(11)70062-1
27. Schrag, A., Horsfall, L., Walters, K., Noyce, A., and Petersen, I. (2015). Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol. 14, 57-64. doi: 10.1016/S1474-4422(14)70287-X
28. Svenningsson, P., Westman, E., Ballard, C., and Aarsland, D. (2012). Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 11, 697-707. doi: 10.1016/S1474-4422(12)70152-7
29. Thaler, A., Mirelman, A., Gurevich, T., Simon, E., Orr-Urtreger, A., Marder, K., et al. (2012). Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology 79, 1027-1032. doi: 10.1212/WNL.0b013e3182684646
30. Walter, U. (2011). Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no. J. Neural Transm. (Vienna) 118, 607-612. doi: 10.1007/s00702-010-0564-r7
31. Walter, U., and Skoloudik, D. (2014). Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med. 35, 322-331. doi: 10.1055/s-0033-1356415
32. Yilmaz, R., Behnke, S., Liepelt-Scarfone, I., Roeben, B., Pausch, C., Runkel, A., et al. (2016). Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults. Eur. J. Neurol. 23, 973-978. doi: 10.1111/ene.12974
33. Youn, S., Kim, T., Yoon, I. Y., Jeong, J., Kim, H. Y., Han, J. W., et al. (2015). Progression of cognitive impairments in idiopathic REM sleep behaviour disorder. J. Neurol. Neurosurg. Psychiatry 87, 890-896. doi: 10.1136/jnnp-2015-311437
34. Zokaei, N., McNeill, A., Proukakis, C., Beavan, M., Jarman, P., Korlipara, P., et al. (2014). Visual short-term memory deficits associated with GBA mutation and Parkinson's disease. Brain 137(Pt 8), 2303-2311. doi: 10.1093/brain/awu143